Ładuje się......
Emerging pharmacotherapies for COVID-19
Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress syndrome. It was initially declared as public health emergency if international concern by WHO followed by Pandemic on 12th March 2...
Zapisane w:
| Wydane w: | Biomed Pharmacother |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
The Authors. Published by Elsevier Masson SAS.
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7221369/ https://ncbi.nlm.nih.gov/pubmed/32410772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2020.110267 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|